Redcare Pharmacy Raises 2026 Revenue Outlook Again on German Rx Boom

• Redcare Pharmacy raised its full-year 2026 guidance for the second time, citing continued strong prescription (Rx) revenue growth in Germany.
• The company now expects total revenue growth of 16%–18%, up from its previous forecast of 15%–17%.
• Non-Rx revenue growth guidance remains unchanged at 10%–12%.
• German Rx revenue is now forecast at €730–760 million, compared with the previous range of €680–720 million.
• The revised German Rx forecast represents growth of 45%–51%, up from the previously expected 35%–43%.
• The adjusted EBITDA margin outlook is unchanged at 2.5%–3.0%.

The next important date, Berenberg Non-Deal Roadshow, Helsinki (NDR = “non-deal roadshow”), at Redcare Pharmacy is on 29.09.2026.

The price of Redcare Pharmacy at the time of the news was 64,18EUR and was up +6,29 % compared with the previous day.
14 minutes after the article was published, the price was 65,70EUR this corresponds to a plus of +2,38 % since publication.
At this time, the index SDAX was at 18.189,95PKT (+0,22 %).

Redcare Pharmacy

+0,62 %

+6,36 %

+31,11 %

+8,32 %

-14,72 %

-33,14 %

-45,48 %

+131,29 %

+135,81 %

ISIN:NL0012044747WKN:A2AR94

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max

Redcare Pharmacy direkt bei SMARTBROKER+ handelnKaufVerkauf

Jetzt bis zu 120 € Prämie sichern! Egal ob Trading, Sparen oder beides - bei SMARTBROKER+ ist für alle was dabei. Eröffnen Sie ein Depot bei Smartbroker+ und erhalten als Prämie jetzt bis zu 120 €!

Schreibe Deinen Kommentar